Acrux Ltd has released a press release.
AGM Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Acrux
- FY24 R&D Tax Incentive rebate received
- ASX Small and Mid Cap Conference presentation
- FY24 Full Year Results - Investor Presentation
- Appendix 4E and FY24 Full Year Statutory Accounts
- FDA Approval received for Dapsone Gel, 7.5%
Later from Acrux
- Trading Halt
- FDA Approval - Nitroglycerin Ointment
- Share Placement successfully concluded and SPP launched
- Investor Presentation
- Share Purchase Plan Offer Booklet
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux